DR. G&S SRL
DR. G&S reported total assets of 365,181 € at the end of the 2025 financial year (annual accounts filed with the NBB on 14 Apr 2026).
The score of DR. G&S shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -57 % Total assets +53 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
DR. G&S's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 300,659 € | ||||
| Equity | 92,341 € | ||||
| Cash | 271,731 € | ||||
| EBITDA | 419,633 € | ||||
| Total assets | 365,181 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 14 Apr 2026
- Year ended 31 Dec 2024filed on 19 Jun 2025
- Year ended 31 Dec 2023filed on 11 Jun 2024
- Year ended 31 Dec 2022filed on 28 Jun 2023
- Year ended 31 Dec 2021filed on 30 Jun 2022
DR. G&S's financial analysis
- Solvency25.3%sector median: 72.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of DR. G&S
DR. G&S's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0763.346.547
- VAT number
- BE0763346547
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 08 Feb 2021
- Registered office
- 2990 Wuustwezel
- Latest accounts
- 2025 · filed on 14 Apr 2026
- Activity
- General medical practice activities (NACE 86210)
DR. G&S (SRL) has been based in Wuustwezel since 2021, active in: general medical practice activities. For 2025, it reports a net profit of 300,659 € and equity of 92,341 €; its revenue is not published. Its solvency stands at 25.3%, below the median of its sector (72.4%).
Companies similar to DR. G&S
Companies in the same business, of comparable size and area, outside its group.
- Hostile Manufacture of outerwear Ixelles · balance sheet 365,195 €
- Transmetal Manufacture of basic pharmaceutical products Liège · balance sheet 365,329 €
- Thierry Comps Immo Namur · balance sheet 365,045 €
- DR. Giart M. Hasselt · balance sheet 364,995 €
- Centre DE Therapie Cognitive ET Comportementale Auderghem · balance sheet 364,933 €
Frequently asked questions about DR. G&S
What is the revenue of DR. G&S?
DR. G&S files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of DR. G&S?
In Belgium, the VAT number is the company number prefixed with BE: BE0763346547 for DR. G&S, if the company is VAT-registered. Its company number (CBE) is 0763.346.547.
Where is the registered office of DR. G&S?
According to the CBE register, the registered office of DR. G&S is in 2990 Wuustwezel.
What is the equity of DR. G&S?
At the close of the 2025 financial year, the equity of DR. G&S amounts to 92,341 €, a solvency of 25.3% of total assets.
Who manages DR. G&S?
The register lists 2 active mandates at DR. G&S. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of DR. G&S
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →